Researchers find genome sequencing can be used to identify severe intellectual disability

June 5, 2014 by Bob Yirka report
Researchers find genome sequencing can be used to identify severe intellectual disability

(Medical Xpress)—A large team of researchers based in the Netherlands has found that whole genome sequencing can be used to identify a large percentage of patients who have a severe intellectual disability (SID). In their paper published in the journal Nature, the team describes how they took a new approach when analyzing gene sequences of SID patients and found that a pattern of genetic abnormalities could be used to diagnose the disorder with an accuracy of 62 percent.

People with a SID (formerly described as various types of severe mental retardation) typically have a very low IQ and associated difficulties in developing both cognitive and functional skills. As medical science has progressed, parents and doctors have been presented with more and more tools for diagnosing various ailments with babies both before and after birth. A diagnosis of SID, however, has been elusive, often only being recognized when a child reaches an age where cognitive skills become apparent. In this new effort, the researchers describe a new type of whole genome sequencing analysis that they claim can be used to diagnose SID in a large number of cases.

SID is unique in that the condition generally comes about due to genetic abnormalities that are not inherited—something happens after conception to alter the genome. Because of this, testing parents for SID risk in offspring is futile. In this new effort, the researchers obtained DNA samples from 50 people who had the condition, and from their parents. They performed whole genome sequencing on all of the samples and then compared the results of each with all the others and with the number of copies of each gene. Doing so revealed 84 previously unknown sequence variations and eight copy number variations. Many of the variations, the researchers found, were mutations that caused genes to stop functioning.

Using what they'd learned, the team turned the results around and applied them as a diagnostic aid—they found that they were able to identify 21 of the original 50 patients as having SID. That means, they claim, that going forward, whole genome sequencing can be used to identify SID with 62 percent accuracy. The data also adds further proof that the majority of cases of SID are the result of non-inherited genetic anomalies, which means research going forward, can focus on the underlying cause of the gene anomalies, rather than continuing to search for something in the parents' genes.

Explore further: Uncovering clues to the genetic cause of schizophrenia

More information: Genome sequencing identifies major causes of severe intellectual disability, Nature (2014) doi:10.1038/nature13394

Severe intellectual disability (ID) occurs in 0.5% of newborns and is thought to be largely genetic in origin. The extensive genetic heterogeneity of this disorder requires a genome-wide detection of all types of genetic variation. Microarray studies and, more recently, exome sequencing have demonstrated the importance of de novo copy number variations (CNVs) and single-nucleotide variations (SNVs) in ID, but the majority of cases remain undiagnosed. Here we applied whole-genome sequencing to 50 patients with severe ID and their unaffected parents. All patients included had not received a molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and exome sequencing. Notwithstanding this prescreening, 84 de novo SNVs affecting the coding region were identified, which showed a statistically significant enrichment of loss-of-function mutations as well as an enrichment for genes previously implicated in ID-related disorders. In addition, we identified eight de novo CNVs, including single-exon and intra-exonic deletions, as well as interchromosomal duplications. These CNVs affected known ID genes more frequently than expected. On the basis of diagnostic interpretation of all de novo variants, a conclusive genetic diagnosis was reached in 20 patients. Together with one compound heterozygous CNV causing disease in a recessive mode, this results in a diagnostic yield of 42% in this extensively studied cohort, and 62% as a cumulative estimate in an unselected cohort. These results suggest that de novo SNVs and CNVs affecting the coding region are a major cause of severe ID. Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.

Press release

Related Stories

Uncovering clues to the genetic cause of schizophrenia

May 28, 2014
The overall number and nature of mutations—rather than the presence of any single mutation—influences an individual's risk of developing schizophrenia, as well as its severity, according to a discovery by Columbia University ...

A new syndrome caused by mutations in AHDC1

May 1, 2014
A team of researchers led by Baylor College of Medicine have identified the gene underlying a newly recognized genetic syndrome that has symptoms of sleep apnea, delayed speech and hyptonia, or generalized upper body weakness.

Powerful tool combs family genomes to find shared variations causing disease

May 29, 2014
Scientists at the University of Utah (U of U), the University of Texas MD Anderson Cancer Center in Houston and colleagues have developed a powerful tool called pVAAST that combines linkage analysis with case control association ...

Researchers develop sequencing platform that generates "clinical-grade" data from small amounts of tumor sample DNA

May 19, 2014
(Medical Xpress)—A large team of researchers with members from several universities and hospitals in the U.S. has developed a sequencing platform that generates "clinical-grade" data using whole exome sequencing (WES) from ...

Deletions and duplications in the exome can help pinpoint cause of unexplained genetic diseases

June 1, 2014
Analysis of genetic variation in the exome, the DNA sequence of genes that are translated into protein, can aid in uncovering the cause of conditions for which no genetic cause could previously be found, and this can directly ...

Study finds large proportion of intellectual disability is not genetically inherited

September 26, 2012
New research published Online First in The Lancet suggests that a high proportion of severe intellectual disability results from genetic causes that are not inherited. These findings are good news for parents, indicating ...

Recommended for you

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jun 05, 2014
Quick! Administer this test to everyone in congress! Never mind, we already know the results...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.